Recurrence of autoimmunity following pancreas transplantation

Current Diabetes Reports

Volumn 11, Issue 5, 2011, Pages 413-419

  Burke III, George W ^a   Vendrame, Francesco ^a   Pileggi, Antonello ^a   Ciancio, Gaetano ^a   Reijonen, Helena ^b   Pugliese, Alberto ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c NONE

Author keywords

Autoantibodies; Autoimmunity; GAD65; Pancreas transplantation; Recurrent diabetes; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; C PEPTIDE; DACLIZUMAB; INSULIN; RITUXIMAB; THYMOCYTE ANTIBODY;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DESTRUCTION; CHRONIC GRAFT REJECTION; DRUG EFFICACY; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MEMORY T LYMPHOCYTE; PANCREAS BIOPSY; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; RECURRENT DISEASE; SINGLE DRUG DOSE;

AUTOANTIBODIES; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; HUMANS; PANCREAS TRANSPLANTATION;

EID: 80755153613     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-011-0206-y     Document Type: Article

References (50)

1. White SA, Shaw JA, Sutherland DE. Pancreas transplantation. Lancet. 2009;373(9677):1808-17.
2. Sageshima J, Ciancio G, Gaynor JJ, et al. Addition of anti-CD25 to thymoglobulin for induction therapy: delayed return of peripheral blood CD25-positive population. Clin Transplant. 2011;25(2):E132-5.
3. Neidlinger N, Singh N, Klein C, et al. Incidence of and risk factors for posttransplant diabetes mellitus after pancreas transplantation. Am J Transplant. 2010;10(2):398-406.
4. Dean PG, Kudva YC, Larson TS, Kremers WK, Stegall MD. Posttransplant diabetes mellitus after pancreas transplantation. Am J Transplant. 2008;8(1):175-82.
5. Sutherland DE, Sibley R, Xu XZ, et al. Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes. Trans Assoc Am Physicians. 1984;97:80-7.
6. Sibley RK, Sutherland DE, Goetz F, Michael AF. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest. 1985;53(2):132-44. (Pubitemid 15049005)
7. Sutherland DE, Goetz FC, Sibley RK. Recurrence of disease in pancreas transplants. Diabetes. 1989;38(S1):85-7. (Pubitemid 19029246)
8. Tyden G, Reinholt FP, Sundkvist G, Bolinder J. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med. 1996;335(12):860-3. (Pubitemid 26304068)
9. Santamaria P, Nakhleh RE, Sutherland DE, Barbosa JJ. Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes. 1992;41 (1):53-61.
10. Vendrame F, Pileggi A, Laughlin E et al. Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 2010;59(4):947-57. This article is the original source for much of the data reviewed in this article.
11. Ishida-Oku M, Iwase M, Sugitani A et al. A case of recurrent type 1 diabetes mellitus with insulitis of transplanted pancreas in simultaneous pancreas-kidney transplantation from cardiac death donor. Diabetologia 2010; 53(2):341-5. This article identified another case of recurrent diabetes in an immunosuppressed patient.
12. Sibley RK, Sutherland DE. Pancreas transplantation. An immunohistologic and histopathologic examination of 100 grafts. Am J Pathol. 1987;128(1):151-70. (Pubitemid 17094345)
13. Bosi E, Bottazzo GF, Secchi A, et al. Islet cell autoimmunity in type I diabetic patients after HLA-mismatched pancreas transplantation. Diabetes. 1989;38(S1):82-4. (Pubitemid 19029245)
14. Esmatjes E, Rodriguez-Villar C, Ricart MJ, et al. Recurrence of immunological markers for type 1 (insulin-dependent) diabetes mellitus in immunosuppressed patients after pancreas transplantation. Transplantation. 1998;66(1):128-31. (Pubitemid 28341181)
15. Petruzzo P, Andreelli F, McGregor B, et al. Evidence of recurrent type I diabetes following HLA-mismatched pancreas transplantation. Diabetes Metab. 2000;26(3):215-8. (Pubitemid 30435768)
16. Thivolet C, Abou-Amara S, Martin X, et al. Serological markers of recurrent beta cell destruction in diabetic patients undergoing pancreatic transplantation. Transplantation. 2000;69 (1):99-103. (Pubitemid 30062615)
17. Braghi S, Bonifacio E, Secchi A, et al. Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes. 2000;49(2):218-24. (Pubitemid 30071000)
18. Hilbrands R, Huurman VA, Gillard P, et al. Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes. 2009;58(10):2267-76.
19. Huurman VA, Hilbrands R, Pinkse GG, et al. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS One. 2008;3(6):e2435.
20. Diamantopoulos S, Allende G, Martin-Pagola A, et al. Recurrence of type 1 diabetes (T1DR) after simultaneous pancreas-kidney (SPK) transplantation is associated with islet cell autoantibody conversion. Acta Diabetol. 2007;44(S1):S13.
21. Sundkvist G, Tyden G, Karlsson FA, Bolinder J. Islet autoimmunity before and after pancreas transplantation in patients with Type I diabetes mellitus. Diabetologia. 1998;41(12):1532-3.
22. Laughlin E, Burke G, Pugliese A, Falk B, Nepom G. Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantation. Clin Immunol. 2008;128 (1):23-30.
23. Reijonen H, Geubtner K, Allende G, et al. Identification of isletautoantigen specific CD4+ T-cells in the pancreatic lymph nodes and pancreas of a pancreas-kidney transplant patient with recurrence of autoimmunity. Diabetes. 2006;55(S1):88A.
24. Tsai EB, Sherry NA, Palmer JP, Herold KC. The rise and fall of insulin secretion in type 1 diabetes mellitus. Diabetologia. 2006;49:261-70. (Pubitemid 43185394)
25. Smukler SR, Arntfield ME, Razavi R, et al. The adult mouse and human pancreas contain rare multipotent stem cells that express insulin. Cell Stem Cell. 2011;8(3):281-93.
26. Bonner-Weir S, Li WC, Ouziel-Yahalom L, et al. Beta-cell growth and regeneration: replication is only part of the story. Diabetes. 2010;59(10):2340-8.
27. Keenan HA, Sun JK, Levine J, et al. Residual insulin production and pancreatic beta-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes. 2010;59(11):2846-53.
28. Meier JJ, Butler AE, Saisho Y, et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of betacell mass in humans. Diabetes. 2008;57(6):1584-94.
29. Butler PC, Meier JJ, Butler AE, Bhushan A. The replication of beta cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab. 2007;3(11):758-68. (Pubitemid 47622601)
30. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC. Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia. 2005;48 (11):2221-8. (Pubitemid 41618910)
31. Melmed RN, Benitez CJ, Holt SJ. Intermediate cells of the pancreas. I. Ultrastructural characterization. J Cell Sci. 1972;11 (2):449-75.
32. Yatoh S, Dodge R, Akashi T, et al. Differentiation of affinitypurified human pancreatic duct cells to beta-cells. Diabetes. 2007;56(7):1802-9. (Pubitemid 47025448)
33. Meier JJ, Ritzel RA, Maedler K, Gurlo T, Butler PC. Increased vulnerability of newly forming beta cells to cytokine-induced cell death. Diabetologia. 2005;49:83-9. (Pubitemid 43151618)
34. Juhl K, Bonner-Weir S, Sharma A. Regenerating pancreatic betacells: plasticity of adult pancreatic cells and the feasibility of invivo neogenesis. Curr Opin Organ Transplant. 2010;15(1):79-85.
35. Martin-Pagola A, Sisino G, Allende G, et al. Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity. Diabetologia. 2008;51(10):1803-13.
36. Jonsson J, Ahlgren U, Edlund T, Edlund H. IPF1, a homeodomain protein with a dual function in pancreas development. Int J Dev Biol. 1995;39(5):789-98. (Pubitemid 26056347)
37. Tanaka S, Kobayashi T, Nakanishi K, et al. Evidence of primary beta-cell destruction by T-cells and beta-cell differentiation from pancreatic ductal cells in diabetes associated with active autoimmune chronic pancreatitis. Diabetes Care. 2001;24(9):1661-7. (Pubitemid 33716466)
38. Bottino R, Criscimanna A, Casu A, et al. Recovery of endogenous beta-cell function in nonhuman primates after chemical diabetes induction and islet transplantation. Diabetes. 2009;58(2):442-7.
39. Wang GS, Rosenberg L, Scott FW. Tubular complexes as a source for islet neogenesis in the pancreas of diabetes-prone BB rats. Lab Invest. 2005;85(5):675-88. (Pubitemid 40675448)
40. Kauri LM, Wang GS, Patrick C, et al. Increased islet neogenesis without increased islet mass precedes autoimmune attack in diabetes-prone rats. Lab Invest. 2007;87(12):1240-51. (Pubitemid 350126710)
41. Xu X, D'Hoker J, Stange G, et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell. 2008;132(2):197-207. (Pubitemid 351181232)
42. Xia B, Zhan XR, Yi R, Yang B. Can pancreatic duct-derived progenitors be a source of islet regeneration? Biochemistry Biophysics Res Commun. 2009;383(4):383-5.
43. Jarchum I, Nichol L, Trucco M, Santamaria P, DiLorenzo TP. Identification of novel IGRP epitopes targeted in type 1 diabetes patients. Clin Immunol. 2008;127(3):359-65.
44. Unger WW, Pinkse GG, der Mulder-van KS, et al. Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men. Ann N YAcad Sci. 2007;1103:192-5. (Pubitemid 46791124)
45. King C, Ilic A, Koelsch K, Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell. 2004;117(2):265-77. (Pubitemid 38496245)
46. Viglietta V, Kent SC, Orban T, Hafler DA. GAD65-reactive Tcells are activated in patients with autoimmune type 1a diabetes. J Clin Invest. 2002;109(7):895-903. (Pubitemid 34275110)
47. Monti P, Scirpoli M, Rigamonti A, et al. Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes. J Immunol. 2007;179(9):5785-92.
48. Monti P, Heninger AK, Bonifacio E. Differentiation, expansion, and homeostasis of autoreactive Tcells in type 1 diabetes mellitus. Curr Diab Rep. 2009;9(2):113-8.
49. Monti P, Scirpoli M, Maffi P et al. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. J. Clin. Invest. 2008;118 (5):1806-14. This article provides evidence for a role of memory cells in patients with islet cell transplants. (Pubitemid 351632383)
50. Matthews JB, Staeva TP, Bernstein PL, Peakman M. von HM. Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group. Clin Exp Immunol. 2010;160(2):176-84.